IB ACQUISITION CORP.

IBAC ·Healthcare, Diagnostics & Research, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023
Operating Activities
Net Income $3.4M $1.9M $-6.8K
Depreciation & Amortization
Depreciation
Amortization
Stock-Based Compensation
Net Cash from Operating Activities $-1.3M $-821.0K $-207
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities $107.8M $-115.6M
Financing Activities
Dividends Paid
Stock Repurchases $106.1M
Net Cash from Financing Activities $-106.1M $117.2M $50.0K
Net Change in Cash
Free Cash Flow